Globyz Biopharma Services, our exclusive sponsor of England and comparator sourcing, is dedicated to sourcing and supplying commercial medicines for analytical research, drug development, clinical trials, or bioequivalence studies across all therapeutic areas.
Based on years of experience, Globyz Biopharma Services possesses strong expertise in managing the regulatory, logistics, and supply chain challenges of sourcing, storing, and distributing pharmaceuticals for clinical trials. Globyz has an international presence, with GMP depots strategically located in the United States, Canada, Germany, India, Singapore, and Brazil, and is expanding its global footprint to meet the growing demand for clinical supply services.
How is Globyz Biopharma Services contributing to the future of healthcare?
Maintaining an innovative culture and investing in innovation is key to Globyz’s overall strategy. Globyz is continually scanning for new technologies to help improve the quality of services, expedite deliveries, and improve overall customer experience.
Globyz is currently finalizing a customized IoT real-time GPS tracking device for end-to-end security, visibility, and data analytics of its assets and temperature-controlled shipments. The company is also monitoring trends in personalized and targeted therapies, the increase of virtual/remote and hybrid trials, direct-to-patient (DTP) services, the application of digital technologies, and the development of more treatments for rare diseases.
The COVID-19 pandemic has had a significant impact on the pharmaceutical industry, as regions are placed on lockdown and companies are faced with API shortages. As a result, the situation has made it apparent that relying on one country for all products and services poses considerable risks and is not a viable long-term strategy. Globyz supports the future of healthcare with streamlined and reliable clinical supply services under one roof as a complete solution, leading to cost and time savings, as well as enhanced compliance.